Moreover, the increased constrictor responses associated with endothelial dysfunction have been ascribed to the reduction in NO-mediated inhibition of the potent vasoconstrictor 20-HETE, with subsequent ROS elevation via CYP1B1-dependent NADPH oxidase activity [5,6,7,8]. The gene discussed is CYP1B1; the disease is endothelial dysfunction.